The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
News Medical on MSN1h
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment optionsMetformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...
KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...
The ability to act upon more than one disease and disorder has led to the GLP-1 analogues market has been getting a ...
Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GIP/GLP-1) ...
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
News Medical on MSN1d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...
Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback